BioWorld 22 janv. 2026 Shanghai Qingrun Pharmaceutical Technology synthesizes new GTPase KRAS mutant inhibitors Shanghai Qingrun Pharmaceutical Technology synthesizes new GTPase KRAS mutant inhibitors Original